{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:55:44Z","timestamp":1791608144547,"version":"4.3.4"},"reference-count":160,"publisher":"American Diabetes Association","issue":"9","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,9,1]]},"DOI":"10.2337\/dc08-0342","type":"journal-article","created":{"date-parts":[[2008,8,27]],"date-time":"2008-08-27T17:33:05Z","timestamp":1219858385000},"page":"1905-1912","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":143,"title":["Ocular Associations of Diabetes Other Than Diabetic Retinopathy"],"prefix":"10.2337","volume":"31","author":[{"given":"V. Swetha E.","family":"Jeganathan","sequence":"first","affiliation":[{"name":"Centre for Eye Research Australia, University of Melbourne, Victoria, Australia"},{"name":"Singapore Eye Research Institute, Singapore National Eye Centre, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie Jin","family":"Wang","sequence":"additional","affiliation":[{"name":"Centre for Eye Research Australia, University of Melbourne, Victoria, Australia"},{"name":"Centre for Vision Research, University of Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien Yin","family":"Wong","sequence":"additional","affiliation":[{"name":"Centre for Eye Research Australia, University of Melbourne, Victoria, Australia"},{"name":"Centre for Vision Research, University of Sydney, New South Wales, Australia"},{"name":"Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031218271760500_R1","doi-asserted-by":"crossref","unstructured":"Congdon NG, Friedman DS, Lietman T: Important causes of visual impairment in the world today. JAMA\u2008290:2057\u20132060, 2003","DOI":"10.1001\/jama.290.15.2057"},{"key":"2022031218271760500_R2","doi-asserted-by":"crossref","unstructured":"Kempen JH, et al: The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol\u2008122:552-563, 2004","DOI":"10.1001\/archopht.122.4.552"},{"key":"2022031218271760500_R3","doi-asserted-by":"crossref","unstructured":"Mohamed Q, Gillies MC, Wong TY: Management of diabetic retinopathy: a systematic review. JAMA\u2008298:902\u2013916, 2007","DOI":"10.1001\/jama.298.8.902"},{"key":"2022031218271760500_R4","unstructured":"Cavallerano JD: A review of non-retinal ocular complications of diabetes mellitus. J Am Optom Assoc\u200861:533\u2013543, 1990"},{"key":"2022031218271760500_R5","unstructured":"American Optometric Association: Optometric Clinical Practice Guideline: Care of the Patient with Diabetes Mellitus [article online]. Available from http:\/\/www.aoa.org\/documents\/CPG-3.pdf. Accessed 25 January 2008"},{"key":"2022031218271760500_R6","doi-asserted-by":"crossref","unstructured":"Stanga PE, Boyd SR, Hamilton AM: Ocular manifestations of diabetes mellitus. Curr Opin Ophthalmol\u200810:483\u2013489, 1999","DOI":"10.1097\/00055735-199912000-00018"},{"key":"2022031218271760500_R7","doi-asserted-by":"crossref","unstructured":"Rowe NG, et al: Diabetes, fasting blood glucose and age-related cataract: the Blue Mountains Eye Study. Ophthalmic Epidemiol\u20087:103\u2013114, 2000","DOI":"10.1076\/0928-6586(200006)721-ZFT103"},{"key":"2022031218271760500_R8","doi-asserted-by":"crossref","unstructured":"Hiller R, Sperduto RD, Ederer F: Epidemiologic associations with nuclear, cortical, and posterior subcapsular cataracts. Am J Epidemiol\u2008124:916\u2013925, 1986","DOI":"10.1093\/oxfordjournals.aje.a114481"},{"key":"2022031218271760500_R9","doi-asserted-by":"crossref","unstructured":"Miglior S, et al: Risk factors for cortical, nuclear, posterior subcapsular and mixed cataract: a case-control study. Ophthalmic Epidemiol\u20081:93\u2013105, 1994","DOI":"10.3109\/09286589409052365"},{"key":"2022031218271760500_R10","doi-asserted-by":"crossref","unstructured":"Delcourt C, et al: Risk factors for cortical, nuclear, and posterior subcapsular cataracts: the POLA study: Pathologies Oculaires Liees a l\u2019Age. Am J Epidemiol\u2008151:497\u2013504, 2000","DOI":"10.1093\/oxfordjournals.aje.a010235"},{"key":"2022031218271760500_R11","doi-asserted-by":"crossref","unstructured":"Klein BE, et al: Older-onset diabetes and lens opacities: the Beaver Dam Eye Study. Ophthalmic Epidemiol\u20082:49\u201355, 2005","DOI":"10.3109\/09286589509071451"},{"key":"2022031218271760500_R12","doi-asserted-by":"crossref","unstructured":"Saxena S, Mitchell P, Rochtchina E: Five-year incidence of cataract in older persons with diabetes and pre-diabetes. Ophthalmic Epidemiol\u200811:271\u2013277, 2004","DOI":"10.1080\/09286580490510733"},{"key":"2022031218271760500_R13","doi-asserted-by":"crossref","unstructured":"McCarty CA, et al: Risk factors for age-related maculopathy: the Visual Impairment Project. Arch Ophthalmol\u2008119:1455\u20131462, 2001","DOI":"10.1001\/archopht.119.10.1455"},{"key":"2022031218271760500_R14","doi-asserted-by":"crossref","unstructured":"Mukesh BN, et al: Development of cataract and associated risk factors: the Visual Impairment Project. Arch Ophthalmol\u2008124:79\u201385, 2006","DOI":"10.1001\/archopht.124.1.79"},{"key":"2022031218271760500_R15","doi-asserted-by":"crossref","unstructured":"Leske MC, Chylack LT Jr, Wu SY: The Lens Opacities Case-Control Study: risk factors for cataract. Arch Ophthalmol\u2008109:244\u2013251, 1991","DOI":"10.1001\/archopht.1991.01080020090051"},{"key":"2022031218271760500_R16","doi-asserted-by":"crossref","unstructured":"Hennis A, et al: Risk factors for incident cortical and posterior subcapsular lens opacities in the Barbados Eye Studies. Arch Ophthalmol\u2008122:525\u2013530, 2004","DOI":"10.1001\/archopht.122.4.525"},{"key":"2022031218271760500_R17","doi-asserted-by":"crossref","unstructured":"Foster PJ, et al: Risk factors for nuclear, cortical and posterior subcapsular cataracts in the Chinese population of Singapore: the Tanjong Pagar Survey. Br J Ophthalmol\u200887:1112\u20131120, 2003","DOI":"10.1136\/bjo.87.9.1112"},{"key":"2022031218271760500_R18","doi-asserted-by":"crossref","unstructured":"Tsai SY, et al: Epidemiologic study of age-related cataracts among an elderly Chinese population in Shih-Pai, Taiwan. Ophthalmology\u2008110:1089\u20131095, 2003","DOI":"10.1016\/S0161-6420(03)00243-4"},{"key":"2022031218271760500_R19","doi-asserted-by":"crossref","unstructured":"Nirmalan PK, et al: Risk factors for age related cataract in a rural population of southern India: the Aravind Comprehensive Eye Study. Br J Ophthalmol\u200888:989\u2013994, 2004","DOI":"10.1136\/bjo.2003.038380"},{"key":"2022031218271760500_R20","doi-asserted-by":"crossref","unstructured":"Leske MC, et al: Diabetes, hypertension, and central obesity as cataract risk factors in a black population: the Barbados Eye Study. Ophthalmology\u2008106:35\u201341, 1999","DOI":"10.1016\/S0161-6420(99)90003-9"},{"key":"2022031218271760500_R21","doi-asserted-by":"crossref","unstructured":"Harding JJ, et al: Diabetes, glaucoma, sex, and cataract: analysis of combined data from two case control studies. Br J Ophthalmol\u200877:2\u20136, 1993","DOI":"10.1136\/bjo.77.1.2"},{"key":"2022031218271760500_R22","doi-asserted-by":"crossref","unstructured":"Bron AJ, et al: The lens in diabetes. Eye\u20087:260\u2013275, 1993","DOI":"10.1038\/eye.1993.60"},{"key":"2022031218271760500_R23","doi-asserted-by":"crossref","unstructured":"Klein BE, Klein R, Lee KE: Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities: the Beaver Dam Eye Study. Am J Ophthalmol\u2008126:782\u2013790, 1998","DOI":"10.1016\/S0002-9394(98)00280-3"},{"key":"2022031218271760500_R24","doi-asserted-by":"crossref","unstructured":"Kato S, et al: Glycemic control and lens transparency in patients with type 1 diabetes mellitus. Am J Ophthalmol\u2008131:301-304, 2001","DOI":"10.1016\/S0002-9394(00)00804-7"},{"key":"2022031218271760500_R25","doi-asserted-by":"crossref","unstructured":"Klein BE, Klein R, Moss SE: Incidence of cataract surgery in the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Am J Ophthalmol\u2008119:295\u2013300, 1995","DOI":"10.1016\/S0002-9394(14)71170-5"},{"key":"2022031218271760500_R26","doi-asserted-by":"crossref","unstructured":"Negahban K, Chern K: Cataracts associated with systemic disorders and syndromes. Curr Opin Ophthalmol\u200813:419-422, 2002","DOI":"10.1097\/00055735-200212000-00013"},{"key":"2022031218271760500_R27","unstructured":"Pirie A: Epidemiological and biochemical studies of cataract and diabetes. Invest Ophthalmol\u20084:629\u2013637, 1965"},{"key":"2022031218271760500_R28","doi-asserted-by":"crossref","unstructured":"Murtha T, Cavallerano J: The management of diabetic eye disease in the setting of cataract surgery. Curr Opin Ophthalmol\u200818:13\u201318, 2007","DOI":"10.1097\/ICU.0b013e32801129fc"},{"key":"2022031218271760500_R29","doi-asserted-by":"crossref","unstructured":"Hykin PG, et al: Extracapsular cataract extraction in proliferative diabetic retinopathy. Ophthalmology\u2008100:394\u2013399, 1993","DOI":"10.1016\/S0161-6420(93)31636-2"},{"key":"2022031218271760500_R30","doi-asserted-by":"crossref","unstructured":"Chew EY, et al: Results after lens extraction in patients with diabetic retinopathy: early treatment diabetic retinopathy study report number 25. Arch Ophthalmol\u2008117:1600\u20131606, 1999","DOI":"10.1001\/archopht.117.12.1600"},{"key":"2022031218271760500_R31","doi-asserted-by":"crossref","unstructured":"Cohen SM, et al: Endopthalmitis after pars plana vitrectomy: the Postvitrectomy Endopthalmitis Study. Opthalmology\u2008102:705\u2013712, 1995","DOI":"10.1016\/S0161-6420(95)30965-7"},{"key":"2022031218271760500_R32","doi-asserted-by":"crossref","unstructured":"Kattan HM, et al: Nosocomial endopthalmitis survey: current injcidence of infection after intreocular surgery. Ophthalmology\u200898:227\u2013238, 1991","DOI":"10.1016\/S0161-6420(91)32312-1"},{"key":"2022031218271760500_R33","doi-asserted-by":"crossref","unstructured":"Montan PG, et al: Endopthalmitis after cataract surgery: risk factors relating to technique and events of the operation and patient history. Ophthalmology\u2008105:2171\u20132177, 1998","DOI":"10.1016\/S0161-6420(98)91211-8"},{"key":"2022031218271760500_R34","doi-asserted-by":"crossref","unstructured":"Scott IU, Flynn HWJ, Feuer W: Endopthalmitis after secondary intraocular lens implantation: a case-control study. Ophthalmology\u2008102:1925\u20131931, 1995","DOI":"10.1016\/S0161-6420(95)30774-9"},{"key":"2022031218271760500_R35","doi-asserted-by":"crossref","unstructured":"Doft BH, et al. : Diabetes and postcataract extraction endopthalmitis. Curr Opin Opthalmol\u200813:147\u2013151, 2002","DOI":"10.1097\/00055735-200206000-00003"},{"key":"2022031218271760500_R36","doi-asserted-by":"crossref","unstructured":"Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch Ophthalmol\u2008114:1366\u20131374, 1996","DOI":"10.1001\/archopht.1996.01100140566007"},{"key":"2022031218271760500_R37","doi-asserted-by":"crossref","unstructured":"Flammer J, et al: The impact of ocular blood flow in glaucoma. Prog Ret Eye Res\u200821:359\u2013393, 2002","DOI":"10.1016\/S1350-9462(02)00008-3"},{"key":"2022031218271760500_R38","doi-asserted-by":"crossref","unstructured":"Piltz-Seymour JR, et al: Optic nerve blood flow is diminished in eyes of primary open-angle glaucoma suspects. Am J Ophthalmol\u2008132:63\u201369, 2001","DOI":"10.1016\/S0002-9394(01)00871-6"},{"key":"2022031218271760500_R39","doi-asserted-by":"crossref","unstructured":"Hayreh SS, et al: Nonarteritic anterior ischemic optic neuropathy: role of nocturnal arterial hypotension. Arch Ophthalmol\u2008115:942\u2013945, 1997","DOI":"10.1001\/archopht.1997.01100160112031"},{"key":"2022031218271760500_R40","doi-asserted-by":"crossref","unstructured":"Arnold AC: Pathogenesis of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol\u200823:157\u2013163, 2003","DOI":"10.1097\/00041327-200306000-00012"},{"key":"2022031218271760500_R41","doi-asserted-by":"crossref","unstructured":"Hayreh SS, Podhajsky PA, Zimmerman B: Ipsilateral recurrence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol\u2008132:734\u2013742, 2001","DOI":"10.1016\/S0002-9394(01)01192-8"},{"key":"2022031218271760500_R42","doi-asserted-by":"crossref","unstructured":"Ischemic Optic Neuropathy Decompression Trial: twenty-four-month update. Arch Ophthalmol\u2008118:793\u2013798, 2000","DOI":"10.1001\/archopht.118.6.793"},{"key":"2022031218271760500_R43","doi-asserted-by":"crossref","unstructured":"Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful: the Ischemic Optic Neuropathy Decompression Trial Research Group. JAMA\u2008273:625\u2013632, 1995","DOI":"10.1001\/jama.273.8.625"},{"key":"2022031218271760500_R44","unstructured":"Yoles E, Wheeler LA, Schwartz M: Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration. Invest Ophthalmol Vis Sci\u200840:65\u201373, 1999"},{"key":"2022031218271760500_R45","doi-asserted-by":"crossref","unstructured":"Kupersmith MJ, et al: Aspirin reduces the incidence of second eye NAION: a retrospective study. J Neuroophthalmol\u200817:250\u2013253, 1997","DOI":"10.1097\/00041327-199712000-00007"},{"key":"2022031218271760500_R46","doi-asserted-by":"crossref","unstructured":"Barr CC, Glaser JS, Blankenship G: Acute disc swelling in juvenile diabetes: clinical profile and natural history of 12 cases. Arch Ophthalmol\u200898:2185\u20132192, 1980","DOI":"10.1001\/archopht.1980.01020041037006"},{"key":"2022031218271760500_R47","doi-asserted-by":"crossref","unstructured":"Bandello F, Menchini F: Diabetic papillopathy as a risk factor for progression of diabetic retinopathy. Retina\u200824:183\u2013184, 2004","DOI":"10.1097\/00006982-200402000-00037"},{"key":"2022031218271760500_R48","doi-asserted-by":"crossref","unstructured":"Sato T, et al: Development of bilateral, nonarteritic anterior ischemic optic neuropathy in an eye with diabetic papillopathy. Jpn J Ophthalmol\u200848:158\u2013162, 2004","DOI":"10.1007\/s10384-003-0034-y"},{"key":"2022031218271760500_R49","doi-asserted-by":"crossref","unstructured":"Hayreh SS, Zahoruk RM: Anterior ischemic optic neuropathy. VI. In juvenile diabetics. Ophthalmologica\u2008182:13\u201328, 1981","DOI":"10.1159\/000309084"},{"key":"2022031218271760500_R50","doi-asserted-by":"crossref","unstructured":"Friedrich Y, et al: Diabetic papillopathy with macular star mimicking clinically significant diabetic macular edema. Retina\u200821:80\u201382, 2001","DOI":"10.1097\/00006982-200102000-00020"},{"key":"2022031218271760500_R51","doi-asserted-by":"crossref","unstructured":"Pavan PR, et al: Optic disc edema in juvenile-onset diabetes. Arch Ophthalmol\u200898:2193\u20135219, 1980","DOI":"10.1001\/archopht.1980.01020041045007"},{"key":"2022031218271760500_R52","doi-asserted-by":"crossref","unstructured":"Al-Haddad CE, Jurdi FA, Bashshur ZF : Intravitreal triamcinolone acetonide for the management of diabetic papillopathy. Am J Ophthalmol\u2008137:1151\u20131153, 2004","DOI":"10.1016\/j.ajo.2004.01.032"},{"key":"2022031218271760500_R53","doi-asserted-by":"crossref","unstructured":"Eshbaugh CG, et al : Simultaneous, multiple cranial neuropathies in diabetes mellitus. J Neuroophthalmol\u200815:219\u2013224, 1995","DOI":"10.1097\/00041327-199512000-00004"},{"key":"2022031218271760500_R54","unstructured":"Singh NP, et al: Multiple cranial nerve palsies associated with type 2 diabetes mellitus. Singapore Med J\u200847:712\u2013715, 2006"},{"key":"2022031218271760500_R55","doi-asserted-by":"crossref","unstructured":"Rush JA: Extraocular muscle palsies in diabetes mellitus. Int Ophthalmol Clin\u200824:155\u2013159, 1984","DOI":"10.1097\/00004397-198402440-00014"},{"key":"2022031218271760500_R56","doi-asserted-by":"crossref","unstructured":"Watanabe K, et al: Characteristics of cranial nerve palsies in diabetic patients. Diabetes Res Clin Pract\u200810:19\u201327, 1990","DOI":"10.1016\/0168-8227(90)90077-7"},{"key":"2022031218271760500_R57","doi-asserted-by":"crossref","unstructured":"Patel SV, et al: Diabetes and hypertension in isolated sixth nerve palsy: a population-based study. Ophthalmology\u2008112:760\u2013763, 2005","DOI":"10.1016\/j.ophtha.2004.11.057"},{"key":"2022031218271760500_R58","doi-asserted-by":"crossref","unstructured":"Burde RM: Neuro-ophthalmic associations and complications of diabetes mellitus. Am J Ophthalmol\u2008114:498\u2013501, 1992","DOI":"10.1016\/S0002-9394(14)71865-3"},{"key":"2022031218271760500_R59","doi-asserted-by":"crossref","unstructured":"Kahn HA, Milton RC: Revised Framingham Eye Study prevalence of glaucoma and diabetic retinopathy. Am J Epidemiol\u2008111:769\u2013776, 1980","DOI":"10.1093\/oxfordjournals.aje.a112955"},{"key":"2022031218271760500_R60","doi-asserted-by":"crossref","unstructured":"Dielemans I, et al: Primary open-angle glaucoma, intraocular pressure, and diabetes mellitus in the general elderly population: the Rotterdam Study. Ophthalmology\u2008103:1271\u20131275, 1996","DOI":"10.1016\/S0161-6420(96)30511-3"},{"key":"2022031218271760500_R61","doi-asserted-by":"crossref","unstructured":"Mitchell P, et al: Open-angle glaucoma and diabetes: the Blue Mountains eye study, Australia. Ophthalmology\u2008104:712\u2013718, 1997","DOI":"10.1016\/S0161-6420(97)30247-4"},{"key":"2022031218271760500_R62","doi-asserted-by":"crossref","unstructured":"Hennis A, et al: Hypertension, diabetes, and longitudinal changes in intraocular pressure. Ophthalmology\u2008110:908\u2013914, 2003","DOI":"10.1016\/S0161-6420(03)00075-7"},{"key":"2022031218271760500_R63","doi-asserted-by":"crossref","unstructured":"Lin HY, et al: Intraocular pressure measured with a noncontact tonometer in an elderly Chinese population: the Shihpai Eye Study. Arch Ophthalmol\u2008123:381-638, 2005","DOI":"10.1001\/archopht.123.3.381"},{"key":"2022031218271760500_R64","doi-asserted-by":"crossref","unstructured":"Bernth-Petersen P, Bach E: Epidemiologic aspects of cataract surgery. III. Frequencies of diabetes and glaucoma in a cataract population. Acta Ophthalmol (Copenh)\u200861:406\u2013416, 1983","DOI":"10.1111\/j.1755-3768.1983.tb01439.x"},{"key":"2022031218271760500_R65","doi-asserted-by":"crossref","unstructured":"Katz J, Sommer A: Risk factors for primary open angle glaucoma. Am J Prev Med\u20084:110\u2013114, 1988","DOI":"10.1016\/S0749-3797(18)31205-4"},{"key":"2022031218271760500_R66","doi-asserted-by":"crossref","unstructured":"Reynolds DC: Relative risk factors in chronic open-angle glaucoma: an epidemiological study. Am J Optom Physiol Opt\u200854:116\u2013120, 1977","DOI":"10.1097\/00006324-197702000-00010"},{"key":"2022031218271760500_R67","doi-asserted-by":"crossref","unstructured":"Morgan RW, Drance SM: Chronic open-angle glaucoma and ocular hypertension: an epidemiological study. Br J Ophthalmol\u200859:211\u2013215, 1975","DOI":"10.1136\/bjo.59.4.211"},{"key":"2022031218271760500_R68","doi-asserted-by":"crossref","unstructured":"Wilson MR, et al: A case-control study of risk factors in open angle glaucoma. Arch Ophthalmol\u2008105:1066\u20131071, 1987","DOI":"10.1001\/archopht.1987.01060080068030"},{"key":"2022031218271760500_R69","doi-asserted-by":"crossref","unstructured":"Tielsch JM, et al: Diabetes, intraocular pressure, and primary open-angle glaucoma in the Baltimore Eye Survey. Ophthalmology\u2008102:48\u201353, 1995","DOI":"10.1016\/S0161-6420(95)31055-X"},{"key":"2022031218271760500_R70","doi-asserted-by":"crossref","unstructured":"Vijaya L, et al: Prevalence of open-angle glaucoma in a rural south Indian population. Invest Ophthalmol Vis Sci\u200846:4461-1167, 2005","DOI":"10.1167\/iovs.04-1529"},{"key":"2022031218271760500_R71","doi-asserted-by":"crossref","unstructured":"Kahn HA, Milton RC: Alternative definitions of open-angle glaucoma: effect on prevalence and associations in the Framingham eye study. Arch Ophthalmol\u200898:2172\u20132177, 1980","DOI":"10.1001\/archopht.1980.01020041024003"},{"key":"2022031218271760500_R72","doi-asserted-by":"crossref","unstructured":"Bengtsson B: The prevalence of glaucoma. Br J Ophthalmol\u200865:46\u201349, 1981","DOI":"10.1136\/bjo.65.1.46"},{"key":"2022031218271760500_R73","doi-asserted-by":"crossref","unstructured":"Armaly MF, et al: Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visual-field defects. Arch Ophthalmol\u200898:2163\u20132171, 1980","DOI":"10.1001\/archopht.1980.01020041015002"},{"key":"2022031218271760500_R74","doi-asserted-by":"crossref","unstructured":"Grunwald JE, et al: Retinal autoregulation in open-angle glaucoma. Ophthalmology\u200891:1690\u20131694, 1984","DOI":"10.1016\/S0161-6420(84)34091-X"},{"key":"2022031218271760500_R75","doi-asserted-by":"crossref","unstructured":"Nakamura M, Kanamori A, Negi A: Diabetes mellitus as a risk factor for glaucomatous optic neuropathy. Ophthalmologica\u2008219:1\u201310, 2005","DOI":"10.1159\/000081775"},{"key":"2022031218271760500_R76","doi-asserted-by":"crossref","unstructured":"Jacobson DR, Murphy RP, Rosenthal AR: The treatment of angle neovascularization with panretinal photocoagulation. Ophthalmology\u200886:1270\u20131277, 1979","DOI":"10.1016\/S0161-6420(79)35407-0"},{"key":"2022031218271760500_R77","doi-asserted-by":"crossref","unstructured":"Zeiter JH, Shin DH, Baek NH: Visual field defects in diabetic patients with primary open-angle glaucoma. Am J Ophthalmol\u2008111:581\u2013584, 1991","DOI":"10.1016\/S0002-9394(14)73702-X"},{"key":"2022031218271760500_R78","doi-asserted-by":"crossref","unstructured":"Mapstone R, Clark CV: Prevalence of diabetes in glaucoma. Br Med J (Clin Res Ed)\u2008291:93\u201395, 1985","DOI":"10.1136\/bmj.291.6488.93"},{"key":"2022031218271760500_R79","unstructured":"Mapstone R, Clark CV: The prevalence of autonomic neuropathy in glaucoma. Trans Ophthalmol Soc UK\u2008104:265\u2013109, 1985"},{"key":"2022031218271760500_R80","doi-asserted-by":"crossref","unstructured":"Clark CV: Autonomic denervation hypersensitivity in the primary glaucomas. Eye\u20083:349\u2013354, 1989","DOI":"10.1038\/eye.1989.50"},{"key":"2022031218271760500_R81","doi-asserted-by":"crossref","unstructured":"Schertzer RM, Wang D, Bartholomew LR: Diabetes mellitus and glaucoma. Int Ophthalmol Clin\u200838:69\u201387, 1998","DOI":"10.1097\/00004397-199803820-00006"},{"key":"2022031218271760500_R82","doi-asserted-by":"crossref","unstructured":"Madsen PH: Experiences in surgical treatment of haemorrhagic glaucoma: a follow-up study. Acta Ophthalmol Suppl\u2008120:88\u201391, 1973","DOI":"10.1111\/j.1755-3768.1973.tb02561.x"},{"key":"2022031218271760500_R83","doi-asserted-by":"crossref","unstructured":"Brown GC, et al : Neovascular glaucoma: etiologic considerations. Ophthalmology\u200891:315\u2013320, 1984","DOI":"10.1016\/S0161-6420(84)34293-2"},{"key":"2022031218271760500_R84","doi-asserted-by":"crossref","unstructured":"Loffler KU: [Neovascular glaucoma: aetiology, pathogenesis and treatment]. Ophthalmologe\u2008103:1057\u20131063, 2006 [Article in German]","DOI":"10.1007\/s00347-006-1431-7"},{"key":"2022031218271760500_R85","doi-asserted-by":"crossref","unstructured":"Hohl RD, Barnett DM: Diabetic hemorrhagic glaucoma. Diabetes\u200819:944\u2013947, 1970","DOI":"10.2337\/diab.19.12.944"},{"key":"2022031218271760500_R86","doi-asserted-by":"crossref","unstructured":"Zirm M: Protein glaucoma\u2013overtaxing of flow mechanisms? Preliminary report. Ophthalmologica\u2008184:155\u2013161, 1982","DOI":"10.1159\/000309199"},{"key":"2022031218271760500_R87","doi-asserted-by":"crossref","unstructured":"Sivak-Callcott JA, et al: Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology\u2008108:1767\u20131776, 2001","DOI":"10.1016\/S0161-6420(01)00775-8"},{"key":"2022031218271760500_R88","unstructured":"Chen CS, Miller NR: Ocular ischemic syndrome: review of clinical presentations, etiology, investigation, and management. Compr Ophthalmol Update\u20088:17\u201328, 2007"},{"key":"2022031218271760500_R89","doi-asserted-by":"crossref","unstructured":"Mizener JB, Podhajsky P, Hayreh SS: Ocular ischemic syndrome. Ophthalmology\u2008104:859\u2013864, 1997","DOI":"10.1016\/S0161-6420(97)30221-8"},{"key":"2022031218271760500_R90","doi-asserted-by":"crossref","unstructured":"Ino-ue M, et al: Ocular ischemic syndrome in diabetic patients. Jpn J Ophthalmol\u200843:31\u201335, 1999","DOI":"10.1016\/S0021-5155(98)00057-4"},{"key":"2022031218271760500_R91","doi-asserted-by":"crossref","unstructured":"Sivalingam A, et al: The ocular ischemic syndrome. II. Mortality and systemic morbidity. Int Ophthalmol\u200813:187\u2013191, 1989","DOI":"10.1007\/BF02028208"},{"key":"2022031218271760500_R92","doi-asserted-by":"crossref","unstructured":"Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis: North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med\u2008325:445\u2013453, 1991","DOI":"10.1056\/NEJM199108153250701"},{"key":"2022031218271760500_R93","doi-asserted-by":"crossref","unstructured":"Kawaguchi S, et al: Effect of carotid endarterectomy on chronic ocular ischemic syndrome due to internal carotid artery stenosis. Neurosurgery\u200848:328\u2013332, 2001","DOI":"10.1227\/00006123-200102000-00016"},{"key":"2022031218271760500_R94","doi-asserted-by":"crossref","unstructured":"Kawaguchi S, et al: Effect of carotid artery stenting on ocular circulation and chronic ocular ischemic syndrome. Cerebrovasc Dis\u200822:402\u2013408, 2006","DOI":"10.1159\/000094859"},{"key":"2022031218271760500_R95","doi-asserted-by":"crossref","unstructured":"Green WR, et al: Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Retina\u20081:27\u201355, 1981","DOI":"10.1097\/00006982-200507001-00008"},{"key":"2022031218271760500_R96","doi-asserted-by":"crossref","unstructured":"Christoffersen NL, Larsen M: Pathophysiology and hemodynamics of branch retinal vein occlusion. Ophthalmology\u2008106:2054\u20132062, 1999","DOI":"10.1016\/S0161-6420(99)90483-9"},{"key":"2022031218271760500_R97","doi-asserted-by":"crossref","unstructured":"Mohamed Q, et al: Interventions for central retinal vein occlusion: an evidence-based systematic review. Ophthalmology\u2008114:507\u2013519, 2007","DOI":"10.1016\/j.ophtha.2006.11.011"},{"key":"2022031218271760500_R98","doi-asserted-by":"crossref","unstructured":"Shahsuvaryan ML, Melkonyan AK: Central retinal vein occlusion risk profile: a case-control study. Eur J Ophthalmol\u200813:445\u2013452, 2003","DOI":"10.1177\/112067210301300505"},{"key":"2022031218271760500_R99","doi-asserted-by":"crossref","unstructured":"Sperduto RD, et al: Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the eye disease case-control study. Ophthalmology\u2008105:765\u2013771, 1998","DOI":"10.1016\/S0161-6420(98)95012-6"},{"key":"2022031218271760500_R100","doi-asserted-by":"crossref","unstructured":"Rath EZ, et al: Risk factors for retinal vein occlusions: a case-control study. Ophthalmology\u200899:509\u2013514, 1992","DOI":"10.1016\/S0161-6420(92)31940-2"},{"key":"2022031218271760500_R101","doi-asserted-by":"crossref","unstructured":"Mitchell P, W. Smith, Chang A: Prevalence and associations of retinal vein occlusion in Australia: the Blue Mountains Eye Study. Arch Ophthalmol\u2008114:1243\u20131247, 1996","DOI":"10.1001\/archopht.1996.01100140443012"},{"key":"2022031218271760500_R102","doi-asserted-by":"crossref","unstructured":"Hayreh SS, et al: Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol\u2008131:61\u201377, 2001","DOI":"10.1016\/S0002-9394(00)00709-1"},{"key":"2022031218271760500_R103","unstructured":"Klein R, et al: The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc\u200898:133\u2013141, 2000"},{"key":"2022031218271760500_R104","doi-asserted-by":"crossref","unstructured":"The Eye Disease Case-Control Study Group: Risk factors for central retinal vein occlusion. Arch Ophthalmol\u2008114:545\u2013554, 1996","DOI":"10.1001\/archopht.1996.01100130537006"},{"key":"2022031218271760500_R105","doi-asserted-by":"crossref","unstructured":"Wong TY, et al: Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the Atherosclerosis Risk in Communities and Cardiovascular Health studies. Ophthalmology\u2008112:540\u2013547, 2005","DOI":"10.1016\/j.ophtha.2004.10.039"},{"key":"2022031218271760500_R106","doi-asserted-by":"crossref","unstructured":"Pinna A, et al: Glucose-6-phosphate dehydrogenase deficiency in retinal vein occlusion. Invest Ophthalmol Vis Sci\u200848:2747\u20132752, 2007","DOI":"10.1167\/iovs.06-1064"},{"key":"2022031218271760500_R107","doi-asserted-by":"crossref","unstructured":"Natural history and clinical management of central retinal vein occlusion: the Central Vein Occlusion Study Group. Arch Ophthalmol\u2008115:486\u2013491, 1997","DOI":"10.1001\/archopht.1997.01100150488006"},{"key":"2022031218271760500_R108","doi-asserted-by":"crossref","unstructured":"West JA, et al: Panretinal photocoagulation during cataract extraction in eyes with active proliferative diabetic eye disease. Eye\u200813:170\u2013173, 1999","DOI":"10.1038\/eye.1999.45"},{"key":"2022031218271760500_R109","unstructured":"Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion: the Central Vein Occlusion Study Group M report. Ophthalmology\u2008102:1425\u20131433, 1995"},{"key":"2022031218271760500_R110","doi-asserted-by":"crossref","unstructured":"Hirano Y, et al: Comparative study on efficacy of a combination therapy of triamcinolone acetonide administration with and without vitrectomy for macular edema associated with branch retinal vein occlusion. Ophthalmic Res\u200839:207\u2013212, 2007","DOI":"10.1159\/000104682"},{"key":"2022031218271760500_R111","unstructured":"Margolis R, Singh RP, Kaiser PK: Branch retinal vein occlusion: clinical findings, natural history, and management. Compr Ophthalmol Update\u20087:265\u2013276, 2006"},{"key":"2022031218271760500_R112","doi-asserted-by":"crossref","unstructured":"Manuchehri K, Kirkby G: Vitreous haemorrhage in elderly patients: management and prevention. Drugs Aging\u200820:655\u2013661, 2003","DOI":"10.2165\/00002512-200320090-00003"},{"key":"2022031218271760500_R113","doi-asserted-by":"crossref","unstructured":"Hawkins WR: Venous occlusive disease review (Letter). Retina\u200827:514, 2007","DOI":"10.1097\/IAE.0b013e3180318fea"},{"key":"2022031218271760500_R114","unstructured":"Funderburk RL, Feinberg EB: Diabetes as a risk factor for retinal neovascularization in retinal vein occlusion. Ann Ophthalmol\u200821:65\u201366, 1989"},{"key":"2022031218271760500_R115","doi-asserted-by":"crossref","unstructured":"Cugati S, et al: Retinal vein occlusion and vascular mortality: pooled data analysis of 2 population-based cohorts. Ophthalmology\u2008114:520\u2013524, 2007","DOI":"10.1016\/j.ophtha.2006.06.061"},{"key":"2022031218271760500_R116","doi-asserted-by":"crossref","unstructured":"Hayreh SS, Zimmerman MB, Podhajsky P: Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol\u2008117:429\u2013441, 1994","DOI":"10.1016\/S0002-9394(14)70001-7"},{"key":"2022031218271760500_R117","doi-asserted-by":"crossref","unstructured":"Lord RS: Transient monocular blindness. Aust N Z J Ophthalmol\u200818:299\u2013305, 1990","DOI":"10.1111\/j.1442-9071.1990.tb00624.x"},{"key":"2022031218271760500_R118","doi-asserted-by":"crossref","unstructured":"Klein R, et al: Retinal emboli and stroke: the Beaver Dam Eye Study. Arch Ophthalmol\u2008117:1063\u20131068, 1999","DOI":"10.1001\/archopht.117.8.1063"},{"key":"2022031218271760500_R119","doi-asserted-by":"crossref","unstructured":"Bruno A, et al: Vascular outcome in men with asymptomatic retinal cholesterol emboli: a cohort study. Ann Intern Med\u2008122:249\u2013253, 1995","DOI":"10.7326\/0003-4819-122-4-199502150-00002"},{"key":"2022031218271760500_R120","doi-asserted-by":"crossref","unstructured":"Klein R, et alL Retinal emboli and cardiovascular disease: the Beaver Dam Eye Study. Arch Ophthalmol\u2008121:1446-14451, 2003","DOI":"10.1001\/archopht.121.10.1446"},{"key":"2022031218271760500_R121","doi-asserted-by":"crossref","unstructured":"Wang JJ, et al: Retinal arteriolar emboli and long-term mortality: pooled data analysis from two older populations. Stroke\u200837:1833\u20131836, 2006","DOI":"10.1161\/01.STR.0000226929.23297.75"},{"key":"2022031218271760500_R122","doi-asserted-by":"crossref","unstructured":"Breen LA: Atherosclerotic carotid disease and the eye. Neurol Clin\u20089:131\u2013145, 1991","DOI":"10.1016\/S0733-8619(18)30307-4"},{"key":"2022031218271760500_R123","doi-asserted-by":"crossref","unstructured":"Recchia FM, Brown GC: Systemic disorders associated with retinal vascular occlusion. Curr Opin Ophthalmol\u200811:462\u2013467, 2000","DOI":"10.1097\/00055735-200012000-00013"},{"key":"2022031218271760500_R124","unstructured":"Hondeghem K, Blanckaert M, Blanckaert J: Branch retinal artery occlusion in systemic diseases: a case report. Bull Soc Belge Ophtalmol\u2008271:9\u201315, 1999"},{"key":"2022031218271760500_R125","doi-asserted-by":"crossref","unstructured":"Klein BE, Klein R, Moss SE: Intraocular pressure in diabetic persons. Ophthalmology\u200891:1356\u201313560, 1984","DOI":"10.1016\/S0161-6420(84)34142-2"},{"key":"2022031218271760500_R126","doi-asserted-by":"crossref","unstructured":"Beatty S, Au Eong KG: Acute occlusion of the retinal arteries: current concepts and recent advances in diagnosis and management. J Accid Emerg Med\u200817:324\u2013329, 2000","DOI":"10.1136\/emj.17.5.324"},{"key":"2022031218271760500_R127","doi-asserted-by":"crossref","unstructured":"Hayreh SS, Zimmerman B, Kardon RH: Visual improvement with corticosteroid therapy in giant cell arteritis: report of a large study and review of literature. Acta Ophthalmol Scand\u200880:355\u2013367, 2002","DOI":"10.1034\/j.1600-0420.2002.800403.x"},{"key":"2022031218271760500_R128","doi-asserted-by":"crossref","unstructured":"Yuzurihara D, Iijima H: Visual outcome in central retinal and branch retinal artery occlusion. Jpn J Ophthalmol\u200848:490\u2013492, 2004","DOI":"10.1007\/s10384-004-0102-y"},{"key":"2022031218271760500_R129","doi-asserted-by":"crossref","unstructured":"Fujishima H, Tsubota K: Improvement of corneal fluorescein staining in post cataract surgery of diabetic patients by an oral aldose reductase inhibitor, ONO-2235. Br J Ophthalmol\u200886:860\u2013863, 2002","DOI":"10.1136\/bjo.86.8.860"},{"key":"2022031218271760500_R130","doi-asserted-by":"crossref","unstructured":"Hiraoka M, et al: Factors contributing to corneal complications after vitrectomy in diabetic patients. Jpn J Ophthalmol\u200845:492\u2013495, 2001","DOI":"10.1016\/S0021-5155(01)00376-8"},{"key":"2022031218271760500_R131","doi-asserted-by":"crossref","unstructured":"Brightbill FS, Myers FL, Bresnick GH: Postvitrectomy keratopathy. Am J Ophthalmol\u200885:651\u2013655, 1978","DOI":"10.1016\/S0002-9394(14)77099-0"},{"key":"2022031218271760500_R132","doi-asserted-by":"crossref","unstructured":"Tabatabay CA, et al: Reduced number of hemidesmosomes in the corneal epithelium of diabetics with proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol\u2008226:389\u2013392, 1988","DOI":"10.1007\/BF02172973"},{"key":"2022031218271760500_R133","unstructured":"Friedman EA: Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications. Diabetes Care\u200822(Suppl. 2):B65\u2013B71, 1999"},{"key":"2022031218271760500_R134","unstructured":"Didenko TN, et al: [Clinical and pathogenetic features of neurotrophic corneal disorders in diabetes]. Vestn Oftalmol\u2008115:7\u201311, 1999 [Article in Russian]"},{"key":"2022031218271760500_R135","doi-asserted-by":"crossref","unstructured":"Tavakoli M, et al: Corneal sensitivity is reduced and relates to the severity of neuropathy in patients with diabetes. Diabetes Care\u200830:1895\u20131897, 2007","DOI":"10.2337\/dc07-0175"},{"key":"2022031218271760500_R136","doi-asserted-by":"crossref","unstructured":"Venkatramani J, Mitchell P: Ocular and systemic causes of retinopathy in patients without diabetes mellitus. BMJ\u2008328:625\u2013629, 2004","DOI":"10.1136\/bmj.328.7440.625"},{"key":"2022031218271760500_R137","doi-asserted-by":"crossref","unstructured":"Vidaurri JS, et al: Association between drusen and some of the risk factors for coronary artery disease. Ophthalmologica\u2008188:243\u2013247, 1984","DOI":"10.1159\/000309370"},{"key":"2022031218271760500_R138","doi-asserted-by":"crossref","unstructured":"Algvere P, et al: Retinal microangiopathy and pigment epithelial lesions in subjects with normal, borderline, and decreased oral glucose tolerance. Br J Ophthalmol\u200869:416\u2013419, 1985","DOI":"10.1136\/bjo.69.6.416"},{"key":"2022031218271760500_R139","doi-asserted-by":"crossref","unstructured":"Kahn HA, et al: The Framingham Eye Study. I. Outline and major prevalence findings. Am J Epidemiol\u2008106:17\u201332, 1977","DOI":"10.1093\/oxfordjournals.aje.a112428"},{"key":"2022031218271760500_R140","doi-asserted-by":"crossref","unstructured":"Hyman LG, et al: Senile macular degeneration: a case-control study. Am J Epidemiol\u2008118:213\u2013227, 1983","DOI":"10.1093\/oxfordjournals.aje.a113629"},{"key":"2022031218271760500_R141","doi-asserted-by":"crossref","unstructured":"Blumenkranz MS, et al: Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology\u200893:552\u2013558, 1986","DOI":"10.1016\/S0161-6420(86)33702-3"},{"key":"2022031218271760500_R142","unstructured":"Maltzman BA, Mulvihill MN, Greenbaum A: Senile macular degeneration and risk factors: a case-control study. Ann Ophthalmol\u200811:1197\u20131201, 1979"},{"key":"2022031218271760500_R143","doi-asserted-by":"crossref","unstructured":"Voutilainen-Kaunisto RM, et al: Age-related macular degeneration in newly diagnosed type 2 diabetic patients and control subjects: a 10-year follow-up on evolution, risk factors, and prognostic significance. Diabetes Care\u200823:1672\u20131678, 2000","DOI":"10.2337\/diacare.23.11.1672"},{"key":"2022031218271760500_R144","doi-asserted-by":"crossref","unstructured":"Hageman GS, et al: An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res\u200820:705\u2013732, 2001","DOI":"10.1016\/S1350-9462(01)00010-6"},{"key":"2022031218271760500_R145","doi-asserted-by":"crossref","unstructured":"Seddon JM, et al: Association between C-reactive protein and age-related macular degeneration. JAMA\u2008291:704\u2013710, 2004","DOI":"10.1001\/jama.291.6.704"},{"key":"2022031218271760500_R146","doi-asserted-by":"crossref","unstructured":"Hammer M, et al: Ocular fundus auto-fluorescence observations at different wavelengths in patients with age-related macular degeneration and diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol\u2008246:105\u2013114, 2008","DOI":"10.1007\/s00417-007-0639-9"},{"key":"2022031218271760500_R147","doi-asserted-by":"crossref","unstructured":"Wong TY, G. Liew, Mitchell P: Clinical update: new treatments for age-related macular degeneration. Lancet\u2008370:204\u2013206, 2007","DOI":"10.1016\/S0140-6736(07)61104-0"},{"key":"2022031218271760500_R148","doi-asserted-by":"crossref","unstructured":"Rosenfeld PJ, et al: Ranibizumab for neovascular age-related macular degeneration. N Engl J Med\u2008355:1419\u20131431, 2006","DOI":"10.1056\/NEJMoa054481"},{"key":"2022031218271760500_R149","doi-asserted-by":"crossref","unstructured":"Gragoudas ES, et al: Pegaptanib for neovascular age-related macular degeneration. N Engl J Med\u2008351:2805\u20132816, 2004","DOI":"10.1056\/NEJMoa042760"},{"key":"2022031218271760500_R150","doi-asserted-by":"crossref","unstructured":"Wong TY, et al: Retinopathy and risk of congestive heart failure. JAMA\u2008293:63\u201369, 2005","DOI":"10.1001\/jama.293.1.63"},{"key":"2022031218271760500_R151","doi-asserted-by":"crossref","unstructured":"Wong TY, Mitchell P: Hypertensive retinopathy signs are independent predictors of cardiovascular diseases (Letter). Br Med J\u2008331:73, 2005","DOI":"10.1093\/bmb\/ldh050"},{"key":"2022031218271760500_R152","doi-asserted-by":"crossref","unstructured":"Wong TY, et al: Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study. Lancet\u2008358:1134\u20131140, 2001","DOI":"10.1016\/S0140-6736(01)06253-5"},{"key":"2022031218271760500_R153","doi-asserted-by":"crossref","unstructured":"Wong TY, et al: Retinal arteriolar narrowing and risk of coronary heart disease in men and women: the Atherosclerosis Risk in Communities Study. JAMA\u2008287:1153\u20131159, 2002","DOI":"10.1001\/jama.287.9.1153"},{"key":"2022031218271760500_R154","doi-asserted-by":"crossref","unstructured":"Wong TY, Mitchell P: Hypertensive retinopathy. N Engl J Med\u2008351:2310\u20132317, 2004","DOI":"10.1056\/NEJMra032865"},{"key":"2022031218271760500_R155","doi-asserted-by":"crossref","unstructured":"Archer DB, Gardiner TA: Ionizing radiation and the retina. Curr Opin Ophthalmol\u20085:59\u201365, 1994","DOI":"10.1097\/00055735-199406000-00011"},{"key":"2022031218271760500_R156","doi-asserted-by":"crossref","unstructured":"Gupta A, et al: Radiation retinopathy: case report and review (Letter). BMC Ophthalmol\u20087:6, 2007","DOI":"10.1186\/1471-2415-7-6"},{"key":"2022031218271760500_R157","doi-asserted-by":"crossref","unstructured":"Viebahn M, Barricks ME, Osterloh MD: Synergism between diabetic and radiation retinopathy: case report and review. Br J Ophthalmol\u200875:629\u2013632, 1991","DOI":"10.1136\/bjo.75.10.629"},{"key":"2022031218271760500_R158","doi-asserted-by":"crossref","unstructured":"Graham CE, et al: Laser photocoagulation: ocular research and therapy in diabetic retinopathy. Adv Exp Med Biol\u2008572:195\u2013200, 2006","DOI":"10.1007\/0-387-32442-9_29"},{"key":"2022031218271760500_R159","doi-asserted-by":"crossref","unstructured":"Kramer M, Lynn W, Lightman S: HIV\/AIDS and the eye. Hosp Med\u200864:421\u2013424, 2003","DOI":"10.12968\/hosp.2003.64.7.2313"},{"key":"2022031218271760500_R160","doi-asserted-by":"crossref","unstructured":"Hoerle S, Kroll P: Evidence-based therapy of diabetic retinopathy. Ophthalmologica\u2008221:132\u2013141, 2007","DOI":"10.1159\/000098258"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/31\/9\/1905\/599716\/zdc00908001905.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/31\/9\/1905\/599716\/zdc00908001905.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T14:29:39Z","timestamp":1647095379000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/31\/9\/1905\/27996\/Ocular-Associations-of-Diabetes-Other-Than"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,1]]},"references-count":160,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc08-0342","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,1]]}}}